Works matching IS 15330028 AND DT 2013 AND VI 12 AND IP 4
Results: 12
The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Fatal Oxaliplatin-Induced Thrombotic Thrombocytopenic Purpura: A Case Report.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 294, doi. 10.1016/j.clcc.2013.09.002
- By:
- Publication type:
- Article
Prognostic Factors in Relation to Racial Disparity in Advanced Colorectal Cancer Survival.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 287, doi. 10.1016/j.clcc.2013.08.001
- By:
- Publication type:
- Article
Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 280, doi. 10.1016/j.clcc.2013.06.001
- By:
- Publication type:
- Article
Timeliness of Adjuvant Chemotherapy for Stage III Adenocarcinoma of the Colon: A Measure of Quality of Care.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 275, doi. 10.1016/j.clcc.2013.08.002
- By:
- Publication type:
- Article
The Prognostic Role of Ephrin A2 and Endothelia Growth Factor Receptor Pathway Mediators in Patients With Advanced Colorectal Cancer Treated With Cetuximab.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 267, doi. 10.1016/j.clcc.2013.07.001
- By:
- Publication type:
- Article
Clinical Significance of Long Intergenic Noncoding RNA-p21 in Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 261, doi. 10.1016/j.clcc.2013.06.003
- By:
- Publication type:
- Article
An Examination of Racial Differences in Process and Outcome of Colorectal Cancer Care Quality Among Users of the Veterans Affairs Health Care System.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 255, doi. 10.1016/j.clcc.2013.06.004
- By:
- Publication type:
- Article
A Phase 1B Study of Dulanermin in Combination With Modified FOLFOX6 Plus Bevacizumab in Patients With Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 248, doi. 10.1016/j.clcc.2013.06.002
- By:
- Publication type:
- Article
Axitinib or Bevacizumab Plus FOLFIRI or Modified FOLFOX-6 After Failure of First-Line Therapy for Metastatic Colorectal Cancer: A Randomized Phase II Study.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 239, doi. 10.1016/j.clcc.2013.09.001
- By:
- Publication type:
- Article
Impact of Physical Activity After Cancer Diagnosis on Survival in Patients With Recurrent Colon Cancer: Findings From CALGB 89803/Alliance.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 233, doi. 10.1016/j.clcc.2013.06.005
- By:
- Publication type:
- Article
Importance of Response to Neoadjuvant Therapy in Patients With Liver-Limited mCRC When the Intent Is Resection and/or Ablation.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 223, doi. 10.1016/j.clcc.2013.06.006
- By:
- Publication type:
- Article